ArticleFrontiers in psychiatry2018

Bone Status in Obese, Non-diabetic, Antipsychotic-Treated Patients, and Effects of the Glucagon-Like Peptide-1 Receptor Agonist Exenatide on Bone Turnover Markers and Bone Mineral Density.

Robert Eriksson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.